BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Gencurix Announces Clinical Research Results At ASCO 2023

Gencurix (KOSDAQ #229000), a leading provider of cancer molecular diagnostics, announced the release of clinical research results directly compa...

June 06, 2023 | News

Massive Bio and TOI Partner to Revolutionize Cancer Care and Research

Under this visionary collaboration, Massive Bio will support TOI with evaluating the eligibility of patients for TOI's active clinical ...

June 05, 2023 | News

YS Biopharma's PIKA Rabies Vaccine Approved for Phase 3 Clinical Trials by Philippines FDA

The Phase 3 clinical trial, which is planned to commence later in 2023, is a multi-center, multi-country study designed to evaluate the safety and immunoge...

June 02, 2023 | News

Aravax doses first patient in Phase 2 peanut allergy clinical trials

Allergy clinical trial centres across Victoria, South Australia, New South Wales, and Western Australia have invited children and ...

June 02, 2023 | News

Avance Clinical at ASCO & BIO 2023: Rising Complexity and Patient Demand in Early Phase Oncology Trials

According to Avance Clinical's Chief Scientific Officer Gabriel Kremmidiotis who is part of the Avance Clinical team attending ASCO:"Recently, Phas...

June 02, 2023 | News

Innovent Collaborates with Merck KGaA to Study Combination Therapy for KRASG12C-mutated NSCLC in China

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...

June 02, 2023 | News

Merck Study: mRNA Technology a ‘Game Changer’ for Asia-Pacific Vaccine Manufacturers

87% of respondents deemed mRNA a key modality for the future More than 60% of vaccine makers surveyed plan revamp or new facilities for mRNA m...

June 01, 2023 | News

Immorna Initiates Phase 1 Study of JCXH-105, a Self-Replicating RNA-Based Shingles Vaccine

"The initiation of our FIH study with JCXH-105 is an important milestone for Immorna and for the development of a potential innovative vaccine for Shingles...

May 31, 2023 | News

Menarini Group's ORSERDU® (Elacestrant) Study Advances in Metastatic Breast Cancer

ORSERDU (elacestrant) was approved by the FDA in January 2023 for advanced or metastatic estrogen receptor (ER)-positive, human epidermal growth factor (...

May 30, 2023 | News

Keio and Osaka Universities Present Non-Clinical Data on Stable/Functional-Induced Regulatory T Cells in Autoimmune Models

Their presentation demonstrated that in a murine pemphigus model, S/F-iTregs significantly decreased clinical scores, circulating anti-Dsg3 IgG titers, and...

May 30, 2023 | News

Amplo Biotech Secures Fast Track Funding for Promising Gene Therapy Targeting Collagen Q Deficiency

Under an exclusive licensing agreement, Amplo Biotechnology has gained access to AAV-ColQ data developed by Professor Kinji Ohno's laboratory at&...

May 30, 2023 | News

Bristol Myers Squibb receives positive CHMP opinion for Opdivo as neoadjuvant treatment for high-risk non-small cell lung cancer

If approved, Opdivo with chemotherapy would be the first and only neoadjuvant immunotherapy-based option authorized to treat patients with non-sm...

May 29, 2023 | Regulatory

Thermo Fisher Scientific and BRIN to Strengthen Research Infrastructure and Capabilities in Indonesia

Thermo Fisher, the world leader in serving science, has signed a Memorandum of Understanding ("MOU") with the National Research and Innovation Agency of&nb...

May 26, 2023 | News

Avance Clinical Joins Global Heath Summit Campaign for Faster Access to Life-Changing and Life-Saving Therapies

Avance Clinical CEO, Yvonne Lungershausen, Chief Scientific Officer Gabriel Kremmidiotis, and Head of Scientific and Regulatory Affairs Jorgen Mould are in...

May 25, 2023 | News

Stay Connected